Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T21:56:28.370Z.
Calculation as of: 2026-10-06T21:56:28.370Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d814f2f9bb590440d28c37f6667649cf2cd18fb847665efd301ef7281cbad61c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$2.22M
PS Ratio
0.36
TTM Avg
0.67
3Y Avg
1.14
5Y Avg
1.89
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Top KingWin Ltd. Class A (DPU) | $2.66M | N/A | N/A | N/A | N/A |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.64M | 0.49 | 0.99 | 2.62 | 4.51 |
| Globavend Holdings Limited (GVH)vs › | $2.71M | 0.09 | 0.24 | 18.72 | 18.72 |
| Intelligent Group Limited (INTJ)vs › | $2.74M | 0.91 | 3.72 | 1.91 | 1.91 |
| DirectBooking Technology Co., Ltd. (ZDAI)vs › | $2.37M | N/A | N/A | N/A | N/A |
| PTL Limited (PTLE)vs › | $2.98M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.00M | 0.96 | 0.78 | 0.76 | 3.74 |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.33M | N/A | N/A | N/A | N/A |
| Professional Diversity Network, Inc. (IPDN)vs › | $2.22M | 0.36 | 0.67 | 1.14 | 1.89 |
| Iveda Solutions, Inc. (IVDA)vs › | $3.17M | 0.69 | 0.35 | 0.98 | 8.80 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute